Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
about
Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteersGalectin-3 as a regulator of the epithelial junction: Implications to wound repair and cancerMMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activationMatrilysin-1 (MMP7) cleaves galectin-3 and inhibits wound healing in intestinal epithelial cellsInterleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implicationLoss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel diseaseMarimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen.Matrix metalloproteinase-7 (matrilysin) controls neutrophil egress by generating chemokine gradients.Helicobacter pylori and gastric cancer: factors that modulate disease risk.Tumour necrosis factor in mouse models of chronic intestinal inflammation.Immunoregulation in the gut: success and failures in human disease.Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformisSubclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex.Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac diseaseExpression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.Fibrogenesis and fibrolysis in collagenous colitis. Patterns of procollagen types I and IV, matrix-metalloproteinase-1 and -13, and TIMP-1 gene expression.Association of Matrix Metalloproteinases -7, -8 and -9 and TIMP -1 with Disease Severity in Acute Pancreatitis. A Cohort StudyMatrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitisBacterial exposure induces and activates matrilysin in mucosal epithelial cells.Lack of MMP10 exacerbates experimental colitis and promotes development of inflammation-associated colonic dysplasia.Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinomaMatrix metalloproteases: underutilized targets for drug deliveryp120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7.Matrilysin expression and function in airway epithelium.Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium.Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.Epithelial cells respond to proteolytic and non-proteolytic detachment by enhancing interleukin-6 responses.Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis.Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively Up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype.Interleukin 1beta induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection.Expression of matrix metalloproteinases and tissue inhibitor metalloproteinases increases in X-irradiated rat ileum despite the disappearance of CD8a T cells.The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis.Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations.Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.Regulation of epithelial cell cytokine responses by the alpha3beta1 integrin.Matrix Metalloproteinases Are Differentially Regulated and Responsive to Compression Therapy in a Red Duroc Model of Hypertrophic Scar.Expressions of MMPs and TIMP-1 in gastric ulcers may differentiate H. pylori-infected from NSAID-related ulcers.
P2860
Q24683276-126ED295-9508-4728-9DEC-2B1CFE5ED2E6Q26785535-25512697-C544-4E53-B355-5B1FB110476CQ27345120-C8BC92D9-E6F7-4CC4-A760-71799DB6259FQ28118886-7B29A163-1EF6-4933-B329-083913F26D65Q28265856-BA61A071-5C27-4149-92B8-9D20198C2368Q30688538-7D301798-B359-49C0-B203-56FB79943AE5Q33177387-96CAAA87-E818-4CA3-A258-44E75E797116Q34070016-54BE789B-6AD3-4961-AA58-D94E04552310Q34189885-462B855B-8AA6-4293-BBC7-1AD77D5F5B55Q34534465-3D811B1D-F61F-434F-8A77-DA75143AF217Q34601009-09C1ABF1-328E-4E65-90C6-C516E00E7BD0Q34792019-57501AD8-976E-4D0A-96B1-87AB4449F896Q35363095-D5366BB6-69C4-4F74-A076-DA3C7CEA98ABQ35549135-ED0F4D0E-7841-46AA-9486-16313F81D2B7Q35565543-9C279B54-6148-41AF-A155-62A6BCF853BFQ35596475-6A92C883-C526-44DA-A1C5-06A93FF9D918Q35787678-45F14A7B-3D20-49F4-8705-F999AFC5511EQ36113242-5E506025-9084-4C96-B185-4F8AC73E931EQ36166985-15DE162F-25DF-4ABF-A62D-FD7BDD6995A7Q36326278-28441B7D-72A3-4927-AD70-334073911FABQ36434492-D15D5218-BEAF-427A-8885-9643AC8D2AB8Q36623544-7A13EE3A-4988-41C7-81DF-5D1DDBDB29A4Q36761849-A511AD37-C284-478F-8926-C28137768999Q36914258-3CF71C3B-9B16-49E6-A7E8-67A28DA3FC03Q37385157-7010B8CD-128F-4D90-8581-7AAA9DC81509Q39896496-E03050F0-ADDD-41D0-AC6E-F614406CBFC7Q40066337-57B224E3-5524-4152-84EB-FC5FE993A73EQ40750574-E6D57206-436D-487A-8C93-34C1469251A8Q41755085-6A8AAED9-E823-459A-92DA-C23ABE477EA7Q41844866-249F3261-86EF-4F74-816B-495D8037645DQ41943857-2E63D07A-B3C3-4E41-9902-B1CF5EF3F414Q42079620-6927F5E1-CB31-410B-98D4-C0168E1A6312Q42104313-9064BAAC-0197-4AE9-BA33-A96E8614C020Q42757053-10134708-99DD-4A34-BF3A-82F704C854F1Q42839432-7B9F6F58-AEE7-4930-828E-E5787A25FFD9Q43006137-6CA124B0-F142-4972-B1AE-4D167C77E1CEQ43086415-CD051CD3-82FF-4920-AF75-678A5B398268Q44299549-3B7D118A-4B3F-4B41-B821-1C934E94571CQ47673790-046AF693-A348-4B73-A89A-1606D8F8C759Q55619702-E7FD490C-C055-4F9A-9F73-C7C5383F71D1
P2860
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Enhanced expression of matrily ...... -1 in gastrointestinal ulcers.
@en
Enhanced expression of matrily ...... -1 in gastrointestinal ulcers.
@nl
type
label
Enhanced expression of matrily ...... -1 in gastrointestinal ulcers.
@en
Enhanced expression of matrily ...... -1 in gastrointestinal ulcers.
@nl
prefLabel
Enhanced expression of matrily ...... -1 in gastrointestinal ulcers.
@en
Enhanced expression of matrily ...... -1 in gastrointestinal ulcers.
@nl
P2093
P2860
P1476
Enhanced expression of matrily ...... -1 in gastrointestinal ulcers.
@en
P2093
Karjalainen-Lindsberg ML
Puolakkainen P
Saarialho-Kere UK
P2860
P304
P407
P577
1996-02-01T00:00:00Z